|
| |
MacroGenics Inc.MacroGenics, Inc. is developing immune-based products including monoclonal antibodies to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases and vaccines to prevent infections in healthy individuals.
| Contact Details: |
| 1500 East Gude Drive |
| Rockville |
| Maryland |
| 20850 |
| United States of America |
| Tel: | 301.251.5172 |
| Fax: | 301.251.5321 |
| Email: | HResources@macrogenics.com |
| WWW: | www.macrogenics.com/
|
|
Loading...
|
Press Releases on MacroGenics Inc.:
|
 |
| Paulo F. Costa Joins MacroGenics Board of Directors |
23rd June, 2009 |
MacroGenics, Inc. |
ROCKVILLE, Md., June 23 /PRNewswire/ -- MacroGenics, Inc. announced today that Mr. Paulo F. Costa has been elected to the company's Board as an independent director. Mr. Costa is the former
|
| MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes |
16th June, 2009 |
|
ROCKVILLE, Maryland and INDIANAPOLIS, June 16 /PRNewswire/ -- MacroGenics, Inc. and Eli Lilly and Company (NYSE: LLY) today announced
that the PROTEGE trial achieved its targeted patient enrollment.
|
| MacroGenics Appoints New Vice President of Business Development |
26th March, 2009 |
MacroGenics, Inc. |
ROCKVILLE, Md., March 26 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today
|
| Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance |
11th December, 2008 |
Eli Lilly and Company |
NEW YORK, Dec. 11 /PRNewswire-FirstCall/ --
-- Innovation and Patient-Centered Approach Expected to Drive Future
Success
-- Lilly Climbs into Top 10 Pharmaceutical Companies in
|
| Lilly Reports Solid Second-Quarter Results |
24th July, 2008 |
Eli Lilly and Company |
INDIANAPOLIS, July 24 /PRNewswire-FirstCall/ -- Eli Lilly and Company
(NYSE: LLY) today announced financial results for the second quarter of 2008.
Second-quarter results are presented on a
|
BioNews Results for MacroGenics Inc.:  | |
| PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis AG, FedEx Corp., Google Inc., Me |
Guru Focus: Nov 22 2009 3:56PM Matching: inc
|
| Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Cogent Inc, AMERICAN PUBLIC EDUCATION, INC, Whitne |
Guru Focus: Nov 22 2009 5:13PM Matching: inc
|
| N.J. index reaches a yearly high |
Asbury Park Press: Nov 22 2009 12:49PM Matching: inc
|
| Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc. |
Individual.com: Nov 21 2009 6:41AM Matching: inc
|
| Stocks That Stand Out For Nov. 20th, 2009 Are ARTS, RFMD, CLDS, ACTC |
Pharmacy Choice: Nov 21 2009 1:27PM Matching: inc
|
| Promote your company here: BioNewsCast - Press Release Distribution | →View more MacroGenics Inc. news. |
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 385 times since April 2007, the link to the organisation's website has been followed 65 times Recent Search Terms used to find this page: MacroGenics | macrogenics logo | MacroGenics Inc | macrogenics inc | macrogenics | macrogenics 2009 | . Search for more companies in Rockville Search for more companies in Maryland This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for MacroGenics Inc. |
